|
US4296206A
(en)
|
1980-04-30 |
1981-10-20 |
United States Of America |
Irreversible anti-glucocorticoids
|
|
US4978657A
(en)
|
1981-01-09 |
1990-12-18 |
Roussel Uclaf |
Novel 11β-substituted-19-nor-steroids
|
|
FR2528434B1
(fr)
|
1982-06-11 |
1985-07-19 |
Roussel Uclaf |
Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
|
|
ZA8231B
(en)
|
1981-01-09 |
1982-11-24 |
Roussel Uclaf |
New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
|
|
FR2639045B2
(fr)
|
1982-03-01 |
1994-07-29 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
|
|
FR2522328B1
(fr)
|
1982-03-01 |
1986-02-14 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
|
|
DE3438994A1
(de)
|
1984-10-22 |
1986-04-24 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Antigestagene, glukokortikoide und prostaglandine zur geburtseinleitung oder fuer den schwangerschaftsabbruch
|
|
FR2576025B1
(fr)
|
1985-01-14 |
1987-01-23 |
Roussel Uclaf |
Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
|
|
AU580843B2
(en)
|
1985-02-07 |
1989-02-02 |
Schering Aktiengesellschaft |
11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
|
|
DE3506785A1
(de)
|
1985-02-22 |
1986-08-28 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US5380840A
(en)
|
1985-09-12 |
1995-01-10 |
The Upjohn Company |
Triazinylpiperazinyl steroids
|
|
FR2598421B1
(fr)
|
1986-05-06 |
1988-08-19 |
Roussel Uclaf |
Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
|
DE3761308D1
(de)
|
1986-07-23 |
1990-02-08 |
Akzo Nv |
18-phenylestrane-derivate.
|
|
DE3625315A1
(de)
|
1986-07-25 |
1988-01-28 |
Schering Ag |
11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4774236A
(en)
|
1986-09-17 |
1988-09-27 |
Research Triangle Institute |
17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
|
|
US4861763A
(en)
|
1986-09-17 |
1989-08-29 |
Research Triangle Institute |
17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
|
|
US4921638A
(en)
|
1986-11-05 |
1990-05-01 |
The Upjohn Company |
17β-cyano-9α,17α-dihydroxyandrost-4-en-3-one
|
|
DE3708942A1
(de)
|
1987-03-18 |
1988-09-29 |
Schering Ag |
19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
DE3723788A1
(de)
|
1987-07-16 |
1989-01-26 |
Schering Ag |
11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
FR2618783B1
(fr)
|
1987-07-30 |
1991-02-01 |
Roussel Uclaf |
Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
|
|
JP2785023B2
(ja)
|
1987-12-30 |
1998-08-13 |
ルセル―ユクラフ |
１７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
|
|
DE3820948A1
(de)
|
1988-06-16 |
1989-12-21 |
Schering Ag |
10ss, 11ss-ueberbrueckte steroide
|
|
US4954490A
(en)
|
1988-06-23 |
1990-09-04 |
Research Triangle Institute |
11 β-substituted progesterone analogs
|
|
US5348729A
(en)
|
1988-11-30 |
1994-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Evaluative means for detecting inflammatory reactivity
|
|
DD289541A5
(de)
|
1989-08-04 |
1991-05-02 |
��@�K@�������������@�K@��������������@��������k�� |
Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen
|
|
US5276023A
(en)
|
1989-08-08 |
1994-01-04 |
Roussel Uclaf |
19-nor-steroid esters
|
|
FR2651233B1
(fr)
|
1989-08-23 |
1991-12-13 |
Roussel Uclaf |
Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
|
|
US5173405A
(en)
|
1990-01-23 |
1992-12-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of arsenite to reversibly block steroid binding to glucocorticoid receptors in the presence of other steroid receptors
|
|
US5616458A
(en)
|
1990-03-14 |
1997-04-01 |
Board Of Regents, University Of Tx System |
Tripterygium wilfordii hook F extracts and components, and uses thereof
|
|
DE4042004A1
(de)
|
1990-12-22 |
1992-06-25 |
Schering Ag |
14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
|
|
US5439913A
(en)
|
1992-05-12 |
1995-08-08 |
Schering Aktiengesellschaft |
Contraception method using competitive progesterone antagonists and novel compounds useful therein
|
|
ZA953976B
(en)
|
1994-05-19 |
1996-01-19 |
Akzo Nobel Nv |
11,21-bisphenyl-19-norpregnane derivatives
|
|
US6051573A
(en)
|
1994-06-28 |
2000-04-18 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists
|
|
US5688808A
(en)
|
1994-12-22 |
1997-11-18 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
|
DE69531998T2
(de)
|
1994-12-22 |
2004-07-22 |
Ligand Pharmaceuticals, Inc., San Diego |
Steroidrezeptor-modulator verbindungen und methoden
|
|
IL118974A
(en)
|
1995-08-17 |
2001-09-13 |
Akzo Nobel Nv |
History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
|
|
US5929058A
(en)
|
1996-12-24 |
1999-07-27 |
Zymogenetics, Inc. |
Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes
|
|
EP0903146A1
(en)
|
1997-09-23 |
1999-03-24 |
Applied Research Systems ARS Holdings N.V. |
21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
IL180679A0
(en)
|
2000-10-27 |
2009-02-11 |
Pfizer Prod Inc |
Process for the preparation of non-steroidal glucocorticoid receptor modulators
|
|
AU2002366217A1
(en)
|
2001-11-23 |
2003-06-10 |
Akzo Nobel N.V. |
Treatment of major depressive disorder using glucocorticoid receptor antagonists
|
|
AU2003287162A1
(en)
|
2002-10-15 |
2004-05-04 |
Medtronic Inc. |
Configuring and testing treatment therapy parameters for a medical device system
|
|
JP2006507311A
(ja)
|
2002-11-05 |
2006-03-02 |
コーセプト セラピューティクス， インコーポレイテッド |
胃食道逆流性疾患を処置するための方法
|
|
EP1761497B1
(en)
|
2004-01-09 |
2008-09-03 |
Corcept Therapeutics, Inc. |
Azadecalin glucocorticoid receptor modulators
|
|
PT1735308E
(pt)
|
2004-03-09 |
2008-12-02 |
Corcept Therapeutics Inc |
Moduladores dos receptores de glucocorticóides de azadecalina de anel fundido
|
|
CA2572544C
(en)
|
2004-07-02 |
2013-02-26 |
Corcept Therapeutics, Inc. |
Modified pyrimidine glucocorticoid receptor modulators
|
|
JP2009535430A
(ja)
*
|
2006-05-02 |
2009-10-01 |
コーセプト セラピューティクス， インコーポレイテッド |
Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
|
|
AU2007309507A1
(en)
|
2006-10-23 |
2008-05-02 |
Merck Sharp & Dohme Corp. |
2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
|
|
US8598149B2
(en)
|
2007-08-30 |
2013-12-03 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
|
|
EP2211845B1
(en)
|
2007-10-17 |
2017-02-22 |
Laboratoire HRA Pharma |
Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome
|
|
EP2429529B1
(en)
|
2009-05-12 |
2015-01-14 |
Corcept Therapeutics, Inc. |
Solid forms and process for preparing
|
|
JP6039587B2
(ja)
|
2011-03-18 |
2016-12-07 |
コーセプト セラピューティクス， インコーポレイテッド |
ピリミジンシクロヘキシルグルココルチコイドレセプター調節因子
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
PL3590517T3
(pl)
*
|
2012-05-25 |
2021-09-20 |
Corcept Therapeutics Incorporated |
Modulatory receptorów glukokortykoidowych typu azadekaliny skondensowanej z heteroaryloketonem
|
|
ITFI20120127A1
(it)
*
|
2012-06-21 |
2013-12-22 |
Valpharma Internat Spa |
Formulazioni per la preparazione di compresse per uso orale a rilascio immediato contenenti mifepristone a basso dosaggio, compresse così ottenute e loro processo di preparazione.
|
|
US20140170768A1
(en)
*
|
2012-12-14 |
2014-06-19 |
Joel R. L. Ehrenkranz |
Method for monitoring and assessing pituitary function
|
|
US9943526B2
(en)
|
2015-04-21 |
2018-04-17 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone levels for cushing's patients
|
|
CA2994422A1
(en)
|
2015-08-13 |
2017-02-16 |
Corcept Therapeutics, Inc. |
Method for differentially diagnosing acth-dependent cushing's syndrome
|